Cell Cryopreservation Market Size to Expand USD 77.52 Bn by 21.05% CAGR till 2034

The global cell cryopreservation market is projected to grow from USD 13.89 billion in 2025 to approximately USD 77.52 billion by 2034, expanding at a CAGR of 21.05% over the forecast period.

Ottawa, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Towards Healthcare, a sister firm of Precedence Research, reports that the global cell cryopreservation market reached USD 11.48 billion in 2024 and is projected to grow to approximately USD 77.52 billion by 2034, expanding at a CAGR of 21.05%.

The growth is driven by the increasing demand for personalized therapy, rising infertility rates, regenerative medicine, and technological advancement fuel the growth of the market.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5361

Key Takeaways

North America dominated the cell cryopreservation market share by 41%.
Asia Pacific is estimated to grow at the fastest rate during the forecast period.
By product, the consumables segment dominated the cell cryopreservation market in 2023.
By product, the freezing media segment is estimated to witness the fastest CAGR in the cell cryopreservation market during the forecast period of 2024-2034.
By application, the stem cells segment held the major share of the cell cryopreservation market in 2023.
By application, the oocytes and embryonic cells segment is estimated to grow at the fastest rate in the cell cryopreservation market during the predicted timeframe.
By end-use, the IVF clinics segment held the largest share of the cell cryopreservation market in 2023.
By end-use, the biobanks segment is expected to achieve the fastest CAGR in the cell cryopreservation market during the forecast period.

Market Overview & Potential

Preserving living cells and tissues at extremely low temperatures, typically with liquid nitrogen (-196°C), is known as cryopreservation. This method allows for long-term storage of biological materials, preventing them from degrading and maintaining their function. To protect cells from damage during freezing and thawing, chemicals like DMSO or glycerol are added to the cell suspension. These chemicals help reduce ice crystal formation. Cells are then cooled at a controlled rate, usually with a programmable freezer or specialized container, to minimize damage. Once frozen, cells are stored in liquid nitrogen for long-term preservation. When needed, cells are quickly thawed to reduce exposure to potentially damaging conditions.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What is the Growth Potential Responsible for The Growth of The Cell Cryopreservation Market?

The growth of the market is driven by the growing demand for personalized therapy and regenerative medicine, which are tailored according to the individual patients which making cryopreservation crucial, fueling the growth of the market. The rising infertility rates, which demand egg and sperm cryopreservation, also influence the demand for the market, driving growth. The technological advancement, like improved cryopreservation techniques and enhanced cell storage and thawing this leads to better and efficient treatment outcomes, fueling the growth and expansion of the market. Other key drivers are rising chronic diseases, government initiatives, organ transplantation, and clinical trials.

What Are the Growing Trends Associated with the Cell Cryopreservation Market?

Stem Cell Banking And Regenerative Medicine

The increasing use of stem cells in the treatment of various diseases is a growing trend used in regenerative medicine and therapies.

Fertility Preservation

The growing demand for reproductive use is a growing trend that contributes to the growth of the market.

Biobanking Initiatives

Investments in large-scale biorepositories fuel the growth and demand for the market.

Automation In Cryopreservation

Integration of automation in the system for enhancing efficiency, sample security, and accuracy fuels the growth of the market.

What Is the Growing Challenge in the Cell Cryopreservation Market?

The key challenge that hinders the growth of the market are cryoinjury and cell damage, compatibility and standardization, long-term storage limitation, regulatory compliance, cost and accessibility, ethical and legal considerations, high initial and operational costs, and market competition limit the growth and expansion of the market.

Regional Analysis

How Did North America Dominate the Cell Cryopreservation Market in 2024?

The North America growth of the cell cryopreservation market is driven by 41% share. The high prevalence of chronic diseases in the region fuels the growth of the market. The other key growth drivers of the market in the region are advanced healthcare infrastructure, research and development investments, government initiatives, rising adoption of personalized medicine, and increased demand for regenerative medicine boost the growth of the market in the region. The key players like BioLife Solutions, Corning, and Thermo Fisher Scientific play a crucial role in the growth and expansion of the market.

What Made the Asia Pacific Significantly Grow in The Cell Cryopreservation Market In 2024?

The growth of the market in the Asia Pacific is driven by various factors, like A growing population, rising healthcare costs, improvements in healthcare infrastructure, and increasing incidence of chronic diseases are major growth drivers. The major drivers are the government support and initiatives for the promotion of biotechnology and life sciences research contribute to the growth of the market. The key players like Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, and Lonza Group Ltd. also play a significant role in the growth, though innovation and cell therapy solutions further fuel the growth and expansion of the market.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Segmental Insights

By product,

Which Product Segment Dominated The Cell Cryopreservation Market In 2024?

The consumables segment dominated the cell cryopreservation market in 2023. Consumables play a crucial role in the cell cryopreservation market as they are required for routine storage and preservation processes. These include cryovials, cryobags, pipettes, and related supplies that ensure sterile handling and safe freezing of biological materials. Their consistent demand from research institutes, biobanks, and IVF clinics drives their growth, as they are indispensable for maintaining sample quality across multiple applications.

The freezing media segment is estimated to witness the fastest CAGR in the cell cryopreservation market during the forecast period of 2024-2034. Freezing media is a vital product segment, formulated to protect cells, tissues, and reproductive materials from damage during ultra-low temperature storage. These specialized media typically contain cryoprotectants that minimize ice crystal formation and preserve cell integrity. Increasing adoption of freezing media in stem cell research, regenerative medicine, and fertility treatments highlights their essential role in ensuring higher cell survival rates post-thaw.

By application,

How Did Stem Cells Segment Dominate The Cell Cryopreservation Market In 2024?

The stem cells segment held the major share of the cell cryopreservation market in 2023. Stem cells are a primary application area for cell cryopreservation, given their importance in regenerative medicine, personalized therapies, and drug discovery. Effective freezing and long-term storage of stem cells are crucial to maintaining their viability and therapeutic potential. Growing investments in stem cell banking and the rising use of stem cells in advanced clinical research further enhance demand within this segment.

The oocytes and embryonic cells segment is estimated to grow at the fastest rate in the cell cryopreservation market during the predicted timeframe. Oocytes and embryonic cells represent a significant application segment, driven by the rising prevalence of fertility treatments and IVF procedures. Cryopreservation enables the long-term storage of reproductive cells while maintaining their viability, which is critical for assisted reproduction technologies. Increasing global awareness of fertility preservation options and expanding IVF clinic networks strengthen the growth of this application.

By end-use,

How did IVF Clinics dominate the Cell Cryopreservation Market in 2024?

The IVF clinics segment held the largest share of the cell cryopreservation market in 2023. IVF clinics account for a substantial share of the cell cryopreservation market as they rely on advanced preservation techniques for reproductive cells and embryos. Cryopreservation supports treatment flexibility and improved success rates, making it integral to modern fertility care. With the growing demand for assisted reproductive technologies, IVF clinics continue to be a key end-user segment.

By end-use, the biobanks segment is expected to achieve the fastest CAGR in the cell cryopreservation market during the forecast period. Biobanks are a critical end-user segment, serving as repositories for a wide range of biological samples, including stem cells, tissues, and genetic material. These facilities require large-scale cryopreservation systems and consumables to ensure long-term sample integrity for research and therapeutic use. The expansion of personalized medicine and genetic research further fuels the reliance of biobanks on cryopreservation solutions.

Get the latest insights on healthcare industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Recent Developments

In September 2024, the novel aseptic micro-connector produced by CPC (Colder Products Company), a division of Dover, is designed to slot straight into the frozen cassettes used in the processing of cell and gene therapy (CGT). Cryopreservation, which involves freezing CGT biological materials at extremely low temperatures, reduces material loss of function that happens during product storage and transportation, which takes place before patient therapy delivery.

In October 2024, according to David Sheehan, CEO of Nucleus Biologics, the introduction of NB-KUL DF ushers in a new era in the cryopreservation of cells employed for therapeutic purposes. This solution will remove negative effects for patients while lowering complexity and expense.

Cell Cryopreservation Market Key Players

Thermo Fisher Scientific Inc.
Merck KGaA
Sartorius AG
PromoCell GmbH
Lonza
HiMedia Laboratories
Creative Biolabs
Corning Incorporated
BioLife Solutions Inc.

Browse More Insights of Towards Healthcare:

The global autologous cell therapy market is valued at USD 9.6 billion in 2024 and is expected to grow to USD 11.41 billion in 2025. By 2034, the market is projected to reach approximately USD 54.21 billion, expanding at a CAGR of 18.9% between 2025 and 2034.

The global autologous stem cell and non-stem cell therapies market is estimated at USD 5.15 billion in 2024 and is anticipated to rise to USD 6.81 billion in 2025. Over the forecast period, it is expected to surge to around USD 82.32 billion by 2034, growing at an impressive CAGR of 32.26%.

The global single cell sequencing market started at USD 1.63 billion in 2024 and is projected to reach USD 1.88 billion in 2025. By 2034, the market is expected to surpass USD 6.65 billion, achieving a steady CAGR of 15.05%.

The global cellular immunotherapy market recorded USD 11.33 billion in 2024, is set to reach USD 13.87 billion in 2025, and is projected to hit nearly USD 85.78 billion by 2034, expanding at a CAGR of 22.45% throughout the forecast period.

The global cell and gene therapy clinical trials market reached USD 10.8 billion in 2024, is expected to grow to USD 12.47 billion in 2025, and is projected to attain around USD 45.31 billion by 2034, expanding at a CAGR of 15.43%.

The global cell-based assays market began at USD 17.29 billion in 2024 and is forecast to rise to USD 18.82 billion in 2025. By the end of 2034, it is expected to exceed USD 39.92 billion, growing at a CAGR of 8.84%.

The global cell and gene solutions market is on a strong upward trajectory, with potential revenues expected to climb significantly over the forecast period from 2025 to 2034.

The global cell-based immunotherapies market is valued at USD 4.59 billion in 2024, expected to reach USD 5.28 billion in 2025, and is projected to grow to approximately USD 18.62 billion by 2034, at a CAGR of 15.02%.

The global cell banking outsourcing market is calculated at USD 14.37 billion in 2024, projected to rise to USD 16.72 billion in 2025, and expected to reach around USD 63.49 billion by 2034, growing at a CAGR of 16.37%.

The global host cell protein testing market is estimated at USD 2.37 billion in 2024, anticipated to grow to USD 2.56 billion in 2025, and projected to reach approximately USD 5.19 billion by 2034, expanding at a CAGR of 8.17%.

Segments Covered in The Report

By Product

Consumables
- Cryogenic Vials
- Cryogenic Tubes
- Cooler Boxes/Containers
- Others
Cell Freezing Media
- Ethylene Glycol
- Dimethyl Sulfoxide
- Glycerol
- Others
Equipment
- Freezers
- Incubators
- Liquid Nitrogen Supply Tanks

By Application

Stem Cells
Oocytes and Embryonic Cells
Sperm Cells
Hepatocytes
Others

By End-use

IVF Clinics
Biobanks
Biopharmaceutical & Pharmaceutical Companies
Research Institutes
Others

By Region

North America
- U.S.
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Latin America
- Brazil
- Mexico
- Argentina
Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5361

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.